Trifluridine/tipiracil HCl mixture

产品说明书

Print
Chemical Structure| 733030-01-8 同义名 : TAS-102;FTD/TPI;TAS102, TAS-102, TAS 102, Trifluridine/tipiracil hydrochloride;Trifluridine-Tipiracil Hydrochloride Mixture;Trifluridine/tipiracil hydrochloride mixture
CAS号 : 733030-01-8
货号 : A705747
分子式 : C19H23Cl2F3N6O7
纯度 : 98%
分子量 : 575.323
MDL号 : MFCD30481309
存储条件:

Pure form Inert atmosphere,Store in freezer, under -20°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 2 mg/mL(3.48 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 100 mg/mL(173.82 mM),配合低频超声助溶

DMF: 20 mg/mL(34.76 mM),配合低频超声助溶

动物实验配方:
生物活性
描述 The Trifluridine/tipiracil hydrochloride mixture (TAS-102) is an effective and orally active nucleoside antitumor agent. Comprised of a 1:0.5 molar ratio of alpha,alpha,alpha-tri-fluorothymidine (FTD) and thymidine phosphorylase inhibitor (TPI), TAS-102 exerts its antitumor effects predominantly through the inhibition of thymidylate synthase (TS) and by being incorporated into DNA[1].[2].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.74mL

0.35mL

0.17mL

8.69mL

1.74mL

0.87mL

17.38mL

3.48mL

1.74mL

参考文献

[1]Emura T, et al. A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells. Int J Mol Med. 2004;13(4):545-549.

[2]Nukatsuka M, et al. Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, with irinotecan hydrochloride on human colorectal and gastric cancer xenografts. Anticancer Res. 2015;35(3):1437-1445.